Advertisement

Discussion

    Published:October 03, 2022DOI:https://doi.org/10.1016/j.surg.2022.08.044
        Dr Martha Zeiger (Bethesda, MD): What are your true next steps? You say you are going to target this, but in what way? With CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology? How are you going to target this pathway?
        To read this article in full you will need to make a payment

        Purchase one-time access:

        Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
        One-time access price info
        • For academic or personal research use, select 'Academic and Personal'
        • For corporate R&D use, select 'Corporate R&D Professionals'

        Subscribe:

        Subscribe to Surgery
        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect